VISTA Science & Technology
October 10, 2006 - Press Release - For Immediate Release
NIAGARA-AREA EXPERT IN TURNING RESEARCH INTO SUCCESSFUL PRODUCTS AND SERVICES, AMY LEMAY, WILL DESCRIBE THE PROCESS IN CHILE
Focus on the end-users, not just the buyers, will be part of her message.
VISTA's transformation process is scientific and replicable
Welland, Ont Tuesday October 10, 2006. - Transforming research into successful products, services and jobs takes disciplined market assessment and market-focused development. That is one message that Amy Lemay, President of Welland-based VISTA Science & Technology will bring to a conference in Chile co-sponsored by the World Bank and Createch, a Chilean organization, during the week of October 16. She will also outline a strategy for making the successful transition from research and development (R&D) to innovations with economic or public benefits.
“Bringing new products to market or creating jobs and wealth is the whole point of investing in R&D,” says Amy Lemay, whose company specializes in turning technology into successes.
Many researchers dream of having a commercial success from their ideas but they stumble when it comes to taking an innovation to market. VISTA's expertise in helping organizations assess the potential of the invention and then taking the disciplined steps to ensure that the innovation can succeed.
“The process of turning an innovation into a benefit passes through common, identifiable stemps; we can accurately predict the outcomes based on verifiable observations and we can control for the factors that affect success,” said Lemay.
VISTA Science & Technology has completed more than 350 technology assessments across a broad range of industries, for both public and private sector clients. The results have helped organizations determine whether to proceed with the development of products or introduce them to potential licensees.
Createch organizers invited Lemay because VISTA's “R&D” Framework approach demonstrates how to assess innovations at the R&D stage, before a technology is developed. This approach also explicitly recognizes that some benefits are social rather than commercial and that the social benefits deserve evaluation as much as do commercial benefits.
Createch expects the conference to attract more than 260 university presidents, laboratory executives, researchers, incubators, and industry representatives whose companies use or generate science and technology innovations. For those who manage publicly-funded R&D Lemay will address their particular interest in ensuring that there will be a public benefit arising from the investment.
The conference will be repeated five times during the week in Santiago, Valparaiso, Coquimbo, Concepcion and Valdivia, Chile. Lemay's co-presenters include industry executives from biotechnology and mining, academics from the United States and from Createch.
VISTA's own assessment method, called R&D Positioning & Prioritizing Framework, uses a variety of methods and scientific tools to assess a research project's commercialization potential and long-term viability in its early stages.
“Its purpose is to identify research projects with the greatest potential benefits. These tools enhance the ability of developers to assess their proposals and make them more competitive, helping to position their projects for commercialization or social good,” Lemay adds. “It's relevant to the business community, to funding agencies and potential investors, becuase we can help to ensure their investment achieves the intended objectives with a greater degree of certainty than ever before.”
VISTA's expertise is aligning science with business by offering a range of market-oriented services for those in the field of research, development and commercialization.
For further information, visit www.vistast.com or contact:
Amy Lemay
President
VISTA Science & Technology
905.734.3000 x 102
alemay@vistast.com
or
Michael Van Dusen
Vice President, Public Relations
Adculture Group Inc
905.817.1245
mvandusen@adculture.com